Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251309 | PMC |
| http://dx.doi.org/10.1111/all.14827 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Determinants of Antibody Reactivity in COVID-19: A Case-Control Study in a Middle Eastern Cohort.
Health Sci Rep
September 2025
Department of Science and Mathematics, School of Interdisciplinary Arts and Sciences University of Washington Tacoma Tacoma Washington USA.
Background And Aims: Understanding the determinants of humoral immunity following COVID-19 infection is essential for guiding vaccination and public health strategies. This study aimed to investigate the association between cycle threshold (Ct) values and SARS-CoV-2-specific antibody reactivity 1 month after recovery in a Middle Eastern cohort, and to identify other contributing factors.
Methods: A case-control study was conducted among COVID-19 patients registered in the Qatar Biobank between March and September 2020.
Correlates of SARS-CoV-2 Breakthrough Infections in Kidney Transplant Recipients Following a Third SARS-CoV-2 mRNA Vaccine Dose.
Vaccines (Basel)
July 2025
Department of Medicine, Gødstrup Hospital, 7400 Herning, Denmark.
Background: Kidney transplant recipients (KTRs) exhibit a significantly diminished immune response to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) vaccines compared with the general population, primarily due to ongoing immunosuppressive therapy. This study evaluated the immunogenicity of a third SARS-CoV-2 mRNA vaccine dose in KTRs and assessed the association between antibody response and protection against SARS-CoV-2 breakthrough infection. Additionally, the clinical and immunological correlates of post-vaccination SARS-CoV-2 infection were examined.
View Article and Find Full Text PDFCytokine profile and early immune response to SARS-CoV-2 in occupationally lead-exposed individuals: A cross-sectional study.
Toxicol Lett
August 2025
Department of Radiology and Radiodiagnostics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Jordana 19, Zabrze 41-808, Poland. Electronic address:
Background: The adaptive immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by the production of various antibodies, with immunoglobulin M (IgM) being the initial isotype synthesized. Lead (Pb), a toxic heavy metal, accumulates in biological systems and disrupts multiple biochemical processes, potentially modulating immune function through alterations in cytokine production and antibody levels.
Objective: This study aimed to elucidate the early immune response to SARS-CoV-2 in lead-exposed individuals by examining antibody profiles and associated immunological parameters.
Convalescent plasma therapy and long-term SARS-COV-2 antiviral immune response in a prospective cohort of patients with COVID-19.
Curr Res Microb Sci
July 2025
Departamento de Enfermedades Infecciosas e Inmunología Pediátricas, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
During the SARS-CoV-2 pandemic, the use of convalescent plasma (CP) in high-risk patients was proposed and widely implemented in several countries as a potential COVID-19 therapy. Nonetheless, CP therapy's impact on immune response is nowadays poorly understood, including the correlation between IgG levels, neutralization capacity, and cellular immune response against SARS-CoV-2. Here we evaluated, in a cohort of patients with COVID-19 requiring hospitalization and having received or not CP, as well as in CP donors (recovered from mild disease), the humoral and cellular immune response assessed by titers of SARS-CoV-2 IgG, neutralizing antibodies, and IFN-γ/IL-2 ELISpot during the first month (early) and up to nine months (long-term) after symptom onset.
View Article and Find Full Text PDFSARS-CoV-2-specific humoral and cellular immunity assessment in Peruvian vaccinated population: a cross-sectional study.
PeerJ
July 2025
Cell Culture and Immunology Lab, Universidad Cientifica del Sur, Lima, Peru.
Background: Evaluating both humoral and cellular immunity is essential for optimizing vaccination strategies and preventing post-pandemic SARS-CoV-2 outbreaks. This cross-sectional study assessed cellular immunity by measuring mRNA expression and humoral immunity through SARS-CoV-2-specific IgG antibodies.
Method: Whole blood samples were collected from 40 Peruvian volunteers.